Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Oncology Reports|May 11, 2006
Potential role of HER-2; in primary breast tumor with bone metastasisRyungsa Kim, Koji Arihiro, Manabu Emi, et al.
Oncology Reports|December 19, 2001
The role of HER-2 oncoprotein in drug-sensitivity in breast cancer (review)Ryungsa Kim, Kazuaki Tanabe, Yoko Uchida, et al.
Breast Cancer Research : BCR|February 19, 2019
Correction to: Targeted therapy against Bcl-2-related proteins in breast cancer cellsManabu Emi, Ryungsa Kim, Kazuaki Tanabe, et al.
Cancer|April 15, 2005
Modulation of tamoxifen sensitivity by antisense Bcl-2 and trastuzumab in breast carcinoma cellsRyungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Anti-Cancer Drugs|January 25, 2003
Inducing cancer cell death by targeting transcription factorsRyungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
Current status of the molecular mechanisms of anticancer drug-induced apoptosis. The contribution of molecular-level analysis to cancer chemotherapyRyungsa Kim, Kazuaki Tanabe, Yoko Uchida, et al.
International Journal of Oncology|March 13, 2003
Antisense Bcl-2 and HER-2 oligonucleotide treatment of breast cancer cells enhances their sensitivity to anticancer drugsKazuaki Tanabe, Ryungsa Kim, Hideki Inoue, et al.
International Journal of Oncology|March 9, 2005
Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancerRyungsa Kim, Kazuaki Tanabe, Manabu Emi, et al.
Pageof 6